Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Bhaskar Shenoy, Anar Andani, Shafi Kolhapure, Ashish Agrawal & Jaydeep Mazumdar. (2022) Endemicity change of hepatitis A infection necessitates vaccination in food handlers: An Indian perspective. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Christian Herzog, Koen Van Herck & Pierre Van Damme. (2021) Hepatitis A vaccination and its immunological and epidemiological long-term effects – a review of the evidence. Human Vaccines & Immunotherapeutics 17:5, pages 1496-1519.
Read now
Read now
Yongji Wang, Yangyang Qi, Wenguo Xu, Yuansheng Hu, Ling Wang, Yongpei Yu, Zhiwei Jiang, Jielai Xia, Gang Zeng & Yalong Wang. (2020) Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction. Human Vaccines & Immunotherapeutics 16:10, pages 2559-2564.
Read now
Read now
Anar Andani, Tessa M. van Elten, Eveline M. Bunge, Cinzia Marano, Fernanda Salgado & Kathryn H. Jacobsen. (2020) Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review. Expert Review of Vaccines 19:9, pages 795-805.
Read now
Read now
Thierry Van Effelterre, Adrienne Guignard, Cinzia Marano, Rosalba Rojas & Kathryn H. Jacobsen. (2017) Modeling the hepatitis A epidemiological transition in Brazil and Mexico. Human Vaccines & Immunotherapeutics 13:8, pages 1942-1951.
Read now
Read now
Articles from other publishers (39)
Mina Hannan, Leila Jabalameli, Mohammad Reza Aghasadeghi, Naser Harzandi & Seyed Mehdi Sadat. (2023) Expression and Evaluation of a Novel HAV-VP1 and HBS-Ag Fusion Protein for Potential Applications in Immunization and Diagnosis. Journal of Medical Microbiology and Infectious Diseases 11:3, pages 128-135.
Crossref
Crossref
Alessandra Fallucca, Vincenzo Restivo, Maria Chiara Sgariglia, Marco Roveta & Cecilia Trucchi. (2023) Hepatitis a Vaccine as Opportunity of Primary Prevention for Food Handlers: A Narrative Review. Vaccines 11:7, pages 1271.
Crossref
Crossref
Wagner Izidoro de Brito, Rode Martinho de Oliveira, Jane Silva, Luciana Neves Tubarão, Ana Paula Dinis Ano Bom, Juliana Gil Melgaço, Marcelo Alves Pinto & Francisco José Dutra Souto. (2023) Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine. Journal of Viral Hepatitis 30:7, pages 615-620.
Crossref
Crossref
N. P. Mamchik, T. N. Sitnik & N. V. Gabbasova. (2023) Viral hepatitis A in the Voronezh region: a controlled or «self-controlled» infection?. Sanitarnyj vrač (Sanitary Doctor):4, pages 199-208.
Crossref
Crossref
Anshu Nain, Mohit Kumar & Manidipa Banerjee. (2022) Oligomers of hepatitis A virus (HAV) capsid protein VP1 generated in a heterologous expression system. Microbial Cell Factories 21:1.
Crossref
Crossref
A. V. Gracheva, E. R. Korchevaya, Yu. I. Ammour, D. I. Smirnova, O. S. Sokolova, G. S. Glukhov, A. V. Moiseenko, I. V. Zubarev, R. V. Samoilikov, I. A. Leneva, O. A. Svitich, V. V. Zverev & Evgeny B. Faizuloev. (2022) Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light. Archives of Virology 167:11, pages 2181-2191.
Crossref
Crossref
Maria Yu. Butskaya, Anastasia D. Bushmanova, Ekaterina N. Priyma, Svetlana V. Ogurtsova, Ksenia E. Novak & Elena V. Esaulenko. (2022) Current epidemiological aspects of acute viral hepatitis in Russia. Epidemiology and Infectious Diseases 26:2, pages 67-74.
Crossref
Crossref
Adriana Guzman-Holst, Gerardo Luna-Casas, Ana Burguete Garcia, Vicente Madrid-Marina, Maria Yolanda Cervantes-Apolinar, Anar Andani, Gloria Huerta-Garcia & Gilberto Sánchez-González. (2022) Burden of disease and associated complications of hepatitis a in children and adults in Mexico: A retrospective database study. PLOS ONE 17:5, pages e0268469.
Crossref
Crossref
Anar Andani, Pierre van Damme, Eveline M. Bunge, Fernanda Salgado, Rosa C. van Hoorn & Bernard Hoet. (2022) One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review. Vaccine 40:2, pages 196-205.
Crossref
Crossref
Angela Domínguez, Carmen Varela, Núria Soldevila, Conchita Izquierdo, María Guerrero, Marina Peñuelas, Ana Martínez, Pere Godoy, Eva Borràs, Cristina Rius, Núria Torner, Ana María Avellón & Jesús Castilla. (2021) Hepatitis A Outbreak Characteristics: A Comparison of Regions with Different Vaccination Strategies, Spain 2010–2018. Vaccines 9:11, pages 1214.
Crossref
Crossref
Marion Migueres, Sébastien Lhomme & Jacques Izopet. (2021) Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment. Viruses 13:10, pages 1900.
Crossref
Crossref
Kaouther Ayouni, Ghassen Kharroubi, Rym Mallekh, Walid Hammami, Ridha Marouani, Moncef Mhamdi, Afif Ben Salah, Henda Triki & Jihène Bettaieb. (2020) Seroprevalence of hepatitis A virus infection in Central‐West of Tunisia. Journal of Medical Virology 93:6, pages 3666-3671.
Crossref
Crossref
Olga Fagan, Paul Amstrong, Kevin Van Der Merwe, Daniela Crosnoi, Chris Steele, Julia Sopena-Falco & Vikrant Parihar. (2021) Viral hepatitis: A brief introduction, review of management, advances and challenges. World Journal of Meta-Analysis 9:2, pages 139-151.
Crossref
Crossref
Thaninee Prasoppokakorn, Jakapat Vanichanan, Roongruedee Chaiteerakij, Kamonwan Jutivorakool, Suwasin Udomkarnjananun, Krit Pongpirul, Wipusit Taesombat, Salin Wattanatorn, Yingyos Avihingsanon, Kriang Tungsanga, Somchai Eiam-Ong, Kearkiat Praditpornsilpa & Natavudh Townamchai. (2021) A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients. Scientific Reports 11:1.
Crossref
Crossref
Patricia Juliao, Ivonne Abadia, Sarah Welby, Stéphanie Wéry, Digna Wong, Tirza De Léon, Rodrigo DeAntonio, Laura Naranjo, Adrienne Guignard & Cinzia Marano. (2021) Hepatitis A antibody persistence 8 and 10 years after 1-dose and 2-dose vaccination in children from Panama. Vaccine 39:1, pages 26-34.
Crossref
Crossref
Pierre Van Damme & Greet Hendrickx. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
115
125
.
Mikhail I. Mikhailov, Maria A. Lopatukhina, Fedor A. Asadi Mobarhan, Lyudmila Yu. Ilchenko, Tatyana V. Kozhanova, Olga V. Isaeva, Anastasiya A. Karlsen, Ilya A. Potemkin, Vera S. Kichatova, Anna A. Saryglar, Natalia D. Oorzhak & Karen K. Kyuregyan. (2020) Universal Single-Dose Vaccination against Hepatitis A in Children in a Region of High Endemicity. Vaccines 8:4, pages 780.
Crossref
Crossref
Sebastián Marciano, Diego Arufe, Leila Haddad, Manuel Mendizabal, Adrián Gadano, Luis Gaite, Margarita Anders, Laura Garrido, Ana Alicia Martinez, Damián Conte, Martin Barrabino, Lucrecia Rovey, Maria Del Valle Aubone, Natalia Ratusnu, Hugo Tanno, Hugo Fainboim, Angel Oyervide, Lucia de Labra, Andrés Ruf & Melisa Dirchwolf. (2020) Outbreak of hepatitis A in a post-vaccination era: High rate of co-infection with sexually transmitted diseases. Annals of Hepatology 19:6, pages 641-644.
Crossref
Crossref
Daniel Shouval. (2020) The History of Hepatitis A. Clinical Liver Disease 16:S1, pages 12-23.
Crossref
Crossref
Jae Hyoung Im, Hyeong‐Taek Woo, Beomman Ha & Jaehun Jung. (2020) Effectiveness of single‐dose administration of inactivated hepatitis A virus vaccination in the Republic of Korea armed forces, 2013‐2016. Journal of Viral Hepatitis 27:5, pages 537-539.
Crossref
Crossref
Eleonora A.M.L. Mutsaerts, Marta C. Nunes, Sutika Bhikha, Benit T. Ikulinda, Lisa Jose, Anthonet Koen, Andrew Moultrie, Diederick E. Grobbee, Kerstin Klipstein-Grobusch, Adriana Weinberg & Shabir A. Madhi. (2020) Short-term immunogenicity and safety of hepatitis-A and varicella vaccines in HIV-exposed uninfected and HIV-unexposed South African children. Vaccine 38:22, pages 3862-3868.
Crossref
Crossref
Yonghao Guo, Lu Zhang, Daxing Feng, Sheng Zhao, Qian Liu, Jin Xu, Mingxia Lu, Jun Li, Yanyang Zhang & Wanshen Guo. (2020) The impact of universal live attenuated hepatitis A vaccines in Henan, China, 2005–2018. International Journal of Infectious Diseases 93, pages 163-167.
Crossref
Crossref
Inbal Galor, Michal Perry Markovich, Dana Wolf, Meital Haber, Michael Hartal & Eva Avramovich. (2020) Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule. Vaccine 38:7, pages 1593-1596.
Crossref
Crossref
Wagner Izidoro de Brito & Francisco José Dutra Souto. (2020) Vacinação universal contra hepatite A no Brasil: análise da cobertura vacinal e da incidência cinco anos após a implantação do programa. Revista Brasileira de Epidemiologia 23.
Crossref
Crossref
Ryan C. Maves. 2020. Principles and Practice of Maternal Critical Care. Principles and Practice of Maternal Critical Care
231
242
.
Roberto Rossotti & Massimo Puoti. 2020. Sexually Transmitted Infections. Sexually Transmitted Infections
255
275
.
Simone Lanini, Andrew Ustianowski, Raffaella Pisapia, Alimuddin Zumla & Giuseppe Ippolito. (2019) Viral Hepatitis. Infectious Disease Clinics of North America 33:4, pages 1045-1062.
Crossref
Crossref
Patricia Angeleri, Valeria Levite, Gabriela Vidiella, Joaquín Solari, Emma Coronel, Dan Adaszko, Ariel Adaszko, Cecilia Moyano, Diosnel Bouchet, Héctor Cuello, Viviana Molfese, Rosario Skarzauskas, Marcelo Vila, Carlos Falistocco & Maria A. Pando. (2019) Viral hepatitis and Treponema pallidum prevalence in persons who underwent premarital blood tests in Argentina. Scientific Reports 9:1.
Crossref
Crossref
Daniel Shouval. (2019) Immunization against Hepatitis A. Cold Spring Harbor Perspectives in Medicine 9:2, pages a031682.
Crossref
Crossref
Jorge L. Trujillo-Ochoa, Oliver Viera-Segura & Nora A. Fierro. (2019) Challenges in Management of Hepatitis A Virus Epidemiological Transition in Mexico. Annals of Hepatology 18:1, pages 14-22.
Crossref
Crossref
Daniel Shouval. 2019. Viral Hepatitis in Children. Viral Hepatitis in Children
91
102
.
Huey-Ling Chen. 2019. Viral Hepatitis in Children. Viral Hepatitis in Children
55
69
.
Kai Michaelis, Christina Poethko-Müller, Ronny Kuhnert, Klaus Stark & Mirko Faber. (2018) Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany. Scientific Reports 8:1.
Crossref
Crossref
Victoria Chi, Shannon Cleary & Joseph A. BocchiniJrJr. (2018) In pursuit of control and elimination. Current Opinion in Pediatrics 30:5, pages 689-697.
Crossref
Crossref
Christopher D. Boston & Jennifer J. Bryan. (2018) Immunizations in Athletes. Sports Health: A Multidisciplinary Approach 10:5, pages 427-433.
Crossref
Crossref
Margaret K Doll, Caroline Quach & David L Buckeridge. (2018) Evaluation of the Impact of a Rotavirus Vaccine Program on Pediatric Acute Gastroenteritis Hospitalizations: Estimating the Overall Effect Attributable to the Program as a Whole and as a Per-Unit Change in Rotavirus Vaccine Coverage. American Journal of Epidemiology 187:9, pages 2029-2037.
Crossref
Crossref
Vladimir Gilca, Jorge Salmerón-Castro, Chantal Sauvageau, Gina Ogilvie, Monique Landry, Monica Naus & Eduardo Lazcano-Ponce. (2018) Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact. Vaccine 36:32, pages 4800-4805.
Crossref
Crossref
María de los Ángeles Durazo-Arvizu, Karina Azpeitia-Cruz, Roberto Dórame Castillo, Manuel Alberto Cano-Rangel & Norberto Sotelo-Cruz. (2018) Usefulness of N-acetylcysteine as Hepatoprotective Agent in Children Infected by Hepatitis A virus. Pediatric Oncall 15:2.
Crossref
Crossref
Stanley M. Lemon, Jördis J. Ott, Pierre Van Damme & Daniel Shouval. (2018) Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. Journal of Hepatology 68:1, pages 167-184.
Crossref
Crossref